Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 17, 2024

SELL
$21.06 - $27.57 $512,663 - $671,136
-24,343 Reduced 9.42%
234,068 $5.63 Million
Q3 2023

Oct 16, 2023

SELL
$27.56 - $35.7 $400,998 - $519,435
-14,550 Reduced 5.33%
258,411 $7.2 Million
Q2 2023

Jul 19, 2023

SELL
$31.53 - $39.74 $35.7 Million - $45 Million
-1,133,074 Reduced 80.59%
272,961 $9.24 Million
Q1 2023

May 05, 2023

SELL
$32.84 - $42.5 $15.4 Million - $19.9 Million
-467,708 Reduced 24.96%
1,406,035 $57.5 Million
Q4 2022

Jan 25, 2023

SELL
$32.54 - $37.99 $2.69 Million - $3.15 Million
-82,801 Reduced 4.23%
1,873,743 $0
Q3 2022

Oct 25, 2022

BUY
$32.81 - $41.51 $133,667 - $169,111
4,074 Added 0.21%
1,956,544 $64.2 Million
Q2 2022

Jul 22, 2022

BUY
$35.59 - $48.1 $10 Million - $13.6 Million
282,243 Added 16.9%
1,952,470 $75.4 Million
Q1 2022

Apr 21, 2022

BUY
$41.4 - $50.9 $23.5 Million - $28.9 Million
567,289 Added 51.43%
1,670,227 $81.3 Million
Q4 2021

Feb 08, 2022

BUY
$37.73 - $46.74 $2.57 Million - $3.18 Million
68,107 Added 6.58%
1,102,938 $49.7 Million
Q3 2021

Oct 26, 2021

BUY
$39.75 - $44.09 $581,184 - $644,639
14,621 Added 1.43%
1,034,831 $43.3 Million
Q2 2021

Aug 04, 2021

BUY
$40.83 - $45.48 $7.91 Million - $8.81 Million
193,651 Added 23.43%
1,020,210 $44.1 Million
Q1 2021

Apr 28, 2021

SELL
$32.95 - $41.63 $8.02 Million - $10.1 Million
-243,281 Reduced 22.74%
826,559 $33.7 Million
Q4 2020

Jan 26, 2021

BUY
$24.49 - $33.73 $3.89 Million - $5.36 Million
158,857 Added 17.44%
1,069,840 $36.1 Million
Q3 2020

Oct 29, 2020

BUY
$19.71 - $26.07 $252,130 - $333,487
12,792 Added 1.42%
910,983 $22.5 Million
Q2 2020

Jul 27, 2020

BUY
$12.98 - $24.5 $11.7 Million - $22 Million
898,191 New
898,191 $19 Million

Others Institutions Holding NVST

About Envista Holdings Corp


  • Ticker NVST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 163,391,008
  • Market Cap $3.06B
  • Description
  • Envista Holdings Corporation, together with its subsidiaries, engages in the development, sale, and marketing of dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment...
More about NVST
Track This Portfolio

Track Artemis Investment Management LLP Portfolio

Follow Artemis Investment Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artemis Investment Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Artemis Investment Management LLP with notifications on news.